In the latest session, biote Corp (NASDAQ: BTMD) closed at $5.80 down -1.19% from its previous closing price of $5.87. In other words, the price has decreased by -$0.07 from its previous closing price. On the day, 164579 shares were traded.
Ratios:
For a deeper understanding of biote Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 7.81. For the most recent quarter (mrq), Quick Ratio is recorded 4.56 and its Current Ratio is at 5.51.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on February 20, 2024, initiated with a Buy rating and assigned the stock a target price of $9.
On June 24, 2022, Cowen started tracking the stock assigning a Outperform rating and target price of $11.Cowen initiated its Outperform rating on June 24, 2022, with a $11 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 05 ’23 when Conlon Mary Elizabeth sold 6,240 shares for $6.50 per share. The transaction valued at 40,573 led to the insider holds 140,393 shares of the business.
Conlon Mary Elizabeth sold 10,867 shares of BTMD for $64,383 on Apr 04 ’23. The General Counsel now owns 122,402 shares after completing the transaction at $5.92 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTMD now has a Market Capitalization of 209.63M and an Enterprise Value of 235.50M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.12. Its current Enterprise Value per Revenue stands at 1.27 whereas that against EBITDA is 25.50.
Stock Price History:
The Beta on a monthly basis for BTMD is 0.88, which has changed by 3.71% over the last 52 weeks, in comparison to a change of 27.86% over the same period for the S&P500. Over the past 52 weeks, BTMD has reached a high of $8.22, while it has fallen to a 52-week low of $3.65. The 50-Day Moving Average of the stock is 5.07, while the 200-Day Moving Average is calculated to be 5.41.
Shares Statistics:
For the past three months, BTMD has traded an average of 110.44K shares per day and 156.17k over the past ten days. A total of 34.25M shares are outstanding, with a floating share count of 33.19M. Insiders hold about 7.07% of the company’s shares, while institutions hold 49.73% stake in the company. Shares short for BTMD as of Mar 15, 2024 were 754.42k with a Short Ratio of 6.83, compared to 539.31k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.11% and a Short% of Float of 2.29%.
Earnings Estimates
There are 2 different market analysts currently analyzing its stock. On average, analysts expect EPS of $0.05 for the current quarter, with a high estimate of $0.09 and a low estimate of $0.02, while EPS last year was -$0.39. The consensus estimate for the next quarter is $0.08, with high estimates of $0.14 and low estimates of $0.03.
Analysts are recommending an EPS of between $0.57 and $0.17 for the fiscal current year, implying an average EPS of $0.37. EPS for the following year is $0.5, with 2 analysts recommending between $0.76 and $0.24.
Revenue Estimates
A total of 4 analysts believe the company’s revenue will be $46.11M this quarter.It ranges from a high estimate of $47.14M to a low estimate of $45.2M. As of the current estimate, biote Corp’s year-ago sales were $44.2M, an estimated increase of 4.30% from the year-ago figure. For the next quarter, 4 analysts are estimating revenue of $49.89M, an increase of 1.30% less than the figure of $4.30% in the same quarter last year. There is a high estimate of $50.7M for the next quarter, whereas the lowest estimate is $48.64M.
A total of 4 analysts have provided revenue estimates for BTMD’s current fiscal year. The highest revenue estimate was $204M, while the lowest revenue estimate was $201.4M, resulting in an average revenue estimate of $202.1M. In the same quarter a year ago, actual revenue was $185.36M, up 9.00% from the average estimate. Based on 4 analysts’ estimates, the company’s revenue will be $235.88M in the next fiscal year. The high estimate is $250M and the low estimate is $225.2M. The average revenue growth estimate for next year is up 16.70% from the average revenue estimate for this year.
